Dashboard/STRIDES

STRIDES

Strides Pharma Science

Pharma · NSE

News sentiment (5 articles)

0 bull4 neutral1 bear

Valuation Gauge

—— Margin of Safety

OVERVALUEDFAIRLY VALUEDUNDERVALUED

Current Price

—

Fair Value

₹1,110

Fair Value Analysis

₹1,110

Based on earnings growth potential for Pharma sector companies | ROCE improving (latest 31.5%) — capital allocation becoming more efficient.

Low confidence

Growth Valuation

100% weight

₹1,110

Price vs Market

STRIDES

Nifty 50

Shareholding Pattern

Stock Health Score

Mixed Signals

4.9 / 10

17% data

Profitability

5/10

EPS of ₹55.5 — ROE data unavailable for full scoring

Debt & Leverage

5/10

Debt data unavailable — scored neutral

Valuation vs Peers

5/10

P/E data unavailable — scored neutral

Cash Flow

5/10

Cash flow data unavailable — scored neutral

Earnings Growth

5/10

Growth data unavailable — scored neutral

Dividend

4/10

No dividend — typical for growth-stage companies

Sentiment Trend — Last 30 Days

Historical Returns

Key Financials

EPS (TTM)

₹55.5

P/E Ratio

—

P/B Ratio

—

ROE

—

ROCE

—

Debt / Equity

—

Beta

—

Div Yield

—

FCF (Cr)

—

Revenue (Cr)

—

EPS Growth 5Y

—

Mkt Cap (Cr)

—

52W High

—

52W Low

—

Book Value/Share

—

Financial History

Period	Revenue	Op Profit	OPM%	PAT	EPS
TTM	—	₹902 Cr	19.0%	—	₹55.48
2025-03-31	—	₹803 Cr	18.0%	—	₹389.75
2024-03-31	—	₹528 Cr	14.0%	—	₹-7.68
2023-03-31	—	₹145 Cr	4.0%	—	₹-22.44
2022-03-31	—	₹-131 Cr	-4.0%	—	₹-51.25
2021-03-31	—	₹537 Cr	16.0%	—	₹29.93
2020-03-31	—	₹414 Cr	15.0%	—	₹4.06
2019-03-31	—	₹197 Cr	9.0%	—	₹36.27
2018-03-31	—	₹398 Cr	14.0%	—	₹74.25
2017-03-31	—	₹527 Cr	19.0%	—	₹44.71
2016-03-31	—	₹374 Cr	13.0%	—	₹12.15
2015-03-31	—	₹229 Cr	19.0%	—	₹141.78
2014-03-31	—	₹-226 Cr	-17.0%	—	₹296.43

Compounded Growth Rates

Sales Growth

3Y—

5Y—

10Y—

Profit Growth

3Y—

5Y—

10Y—

EPS Growth

3Y—

5Y+13.1%

10Y+16.4%

Peer Comparison

Pharma

Stock	Price	Fair Value	MoS%	P/E	ROE	Signal
PAR Par Drugs And Chemicals Limited	₹86	₹469.7	+81.7%	7.3	15.4%	FAIRLY_VALUED
IOLCP IOL Chemicals and Pharmaceuticals Limited	₹79.5	₹237.8	+66.6%	19.6	5.2%	FAIRLY_VALUED
KILITCH Kilitch Drugs (India) Limited	₹132.7	₹321	+58.7%	17.7	9.4%	UNDERVALUED
BALPHARMA Bal Pharma Limited	₹69	₹147.5	+53.2%	12.8	12.6%	FAIRLY_VALUED
ZYDUSLIFE Zydus Lifesciences	₹868	₹1,502.2	+42.2%	17.6	19.9%	UNDERVALUED
NATCOPHARM Natco Pharma	₹1,030	₹1,597	+35.5%	11.8	18.0%	UNDERVALUED
JAGSNPHARM Jagsonpal Pharmaceuticals Limited	₹190.6	₹275.2	+30.7%	30.8	20.1%	UNDERVALUED
LUPIN Lupin	₹2,280	₹3,112	+26.7%	22.4	23.8%	UNDERVALUED